Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures

A Phase 2a, Open-label,Proof -Of-Concept Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures

Evaluate the safety and efficacy of intranasal Clonazepam in subjects with epilepsy.

Inclusion Criteria:

• Diagnosis of refractory epilepsy
• No Nasal conditions that would preclude the use of intranasal product

Exclusion Criteria:

• Subject with a clinical significant unstable medical abnormality
• Subject currently or regularly taking Clonazepam